Introduction
Human pterin-4a-carbinolamine dehydratase/ dimerization cofactor of hepatocyte nuclear factor-l a (in the following abbreviated PC D) is a small protein, which has two apparent functions: It assists the phenylalanine hydroxylase (PAH) reaction in that it catalyzes the dehydration of the intermediate pterin-4a-carbinolamine (1) , and it has been proposed to induce dimerization of the named factorla (2) . The amino acid sequence of the protein has been solved (3), and its 3D-structure has been reported (4). Its CysSIArg mutant has been proposed to cause hyperphenylalaninremia (5) and to be at the origin of the high content of 7-pterins in the patient. We report here on some properties of PCD which has been expressed in E. coli and purified, as well as of two CysSI mutants (Ser and Arg). Details of the present work have been submitted to EJB for publication (6) .
Materials and Methods
A pGEMEX-2-derived vector (Promega) expressing the 104 residues encoding wildtype peD (wt-PCD) starting with methionine and having six Cterminal histidine residues (His-tag) was generated § Author to whom correspondence should be addressed.
Pteridines / Vol. 6 / No.3 by PCR-cloning using the human liver cDNA as a template (see Figure 1 ; (7». To express the mutant proteins C8IS-PCD and CSIR-PCD, PCR-directed mutagenesis was performed using specific oligonucleotides with corresponding mismatches ( Figure I ). Cloning ofPCR products into pGEMEX-2-Nde was performed analogously as for the wild-type PCD. Recombinant expression of wt-PCD, CSIS-PCD, and CSIR-PCD was achieved in E. coli BL21 (DE3) pLysS following a description by Promega. The His-tagged PCD proteins were isolated in a standard one-step affinity purification procedure using a Ni-NTA (nickel-nitrilotriacetic acid) sepharose column (Quiagen).
Results
Details of the expression vectors for wt-PCD, CSIS-PCD and CSIR-PCD are given in Figure 1 . Analysis by ESI-MS of the three affinity purified PCD proteins, and in case of the wt-PCD amino terminal amino acid sequence determination, revealed that they had the N-terminal methionine cleaved off. Thus, these C-terminal poly histidine tagged proteins started with alanine as the first amino acid, similarly to what was found for the mature form of the human (and rat) enzyme (3) .
The prominent catalytic properties of PCD and of its two mutants are summarized in the Table. The wt-PCD expression vector was generated by first performing standa rd PCR amplification with primers PCDHI5 and PCDH20 and the human PCD-cDNA as template. Primer PCDHl5 contains an EcoRI and a Ndel site (italics), the ATG start codon (bold) plus the codons for th e first 6 residues of the mature form of PCD. The amino terminal methionine is in parenthesis because it was found to be cleaved off following recombinant expression in E. coli. Primer PCDH20 encodes the C-terminal seven amino acids of PCD followed by six codons for histidine residues plus a stop codon (bold) and a BamHI restriction site (italics) at its 5'-end. The PCR product encoding the 110 amino acids for the recombinant His-tag PCD was digested with Ndel/BamHI endonucleases and ligated into the expression vector pGEMEX-2-Nde (Promega; a second NdeI site present in the original vector was removed by site-directed mutage nesis). To generate the vectors for expression of muta nt proteins. PCR-directed mutagenesis was performed using primer PCDH24 (for Cys to Ser exch ange) or PCDH26 (for Cys to Arg exchange) in combination with primer PCDH20 (see boxed inset; nucleotide exchanges are in bold and relevant codons are underlined). The PCR products were gel purified and used as primers for a second round of PCR in combination with primer PCDHI5. Products from these second PCR were cloned into pGEMEX-2-Nde in an analogous way as described above.
They show that PCD a nd both mutants expressed in E. coli are active both using the PAH-linked assay (8) and the synthetic substrate 6,6-dimethyl-pterin4a-carbinolamine (DCA). Importantly, the activity values are indistinguishable from those obtained using PCD provided to us by Ficner et al (4), which does not carry the His-tag at the C-terminus. This demonstrates that the His-tag does not affect the catalytic properties or binding of our PCD. These recombinant PCD's all bind biopterin at its three oxidation states and also quinonoid 6,6-dimethyl-7,8-dihydropterin, suggesting the presence of a specific recognition site. PCD contains a single Cys81 sulfbydryl residue. Since the corresponding Ser mutant has closely similar properties, a direct role of Cys81 in catalysis can be excluded. Most importantly the Cys81Arg mutant has lower activity and a significantly higher Krn value in the PAH linked assay or using the synthetic substrate DCA compared to wild-type PCD or its Cys81Ser mutant. This is in keeping with the proposal (5) that this mutation is the origin of the reported genetic dis-
order. On the other hand, when the phenylalanine hydroxylase reaction was carried out u sing 0.1 f.lM Cys81Arg-PCD as the stimulant, the production of 7-pterins was effectively suppressed as is the case with wild-type PCD. 
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